InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Corrigan Mark, Director. Director active across 2 companies, notably Nabriva Therapeutics plc. In total, 5 filings have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €110k. Activity tracked since 28 July 2021. The latest transaction was filed on 8 December 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Mark Corrigan is a Board Member at Nabriva Therapeutics plc. He contributes to the governance of the company by participating in strategic decision-making and ensuring operational compliance. His role is important for the success and growth of the company.